research funding database


This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.

Clinical Research Award (neurofibromatosis)

Share this post

ERC webinar 2024
ERC webinar 2024

The Clinical Research Award (CRA) from the Children’s Tumor Foundation supports early stage pilot clinical trials of candidate therapeutics or interventions for the treatment of physical or psychosocial manifestations of neurofibromatosis (NF)1, schwannomatosis (SWN), or NF2. Applicants may be of any nationality and based anywhere in the world. Applicants must be MDs, PhDs, research fellows, and holders of MS, GC, NP, and equivalent degrees. The Award provides 2 years of funding of up to 150,000 USD, including 10% indirect costs.

Applications open January 16, 2024.

Letters of intent are due on February 12, 2024 and invited full applications are due on April 1, 2024.

The grant has closed Sign-up for our content alerts to be updated when it re-opens.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for the
monthly funding newsletter

unsubscribe at any time